Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 511 AL 525

Connecting dots: Preclinical foundations to clinical realities of PDE4 inhibitors in Alzheimer's disease

Kumari S, Bagri K, Deshmukh R.

Inflammopharmacology. 2025 Feb;33(2):593-603. doi: 10.1007/s10787-024-01638-1. Epub 2025 Jan 14.

Functional Proteins/Peptides Targeting to Clear Amyloid-β for Alzheimer's Disease Therapy

Gao Z, Hou R, Qian C.

Chembiochem. 2025 Feb 16;26(4):e202400912. doi: 10.1002/cbic.202400912. Epub 2025 Jan 23.

Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management

Pei J, Kumarasamy RV, Jayaraman S, Kanniappan GV, Long Q, Palanisamy CP.

Ageing Res Rev. 2025 Feb;104:102665. doi: 10.1016/j.arr.2025.102665. Epub 2025 Jan 15.

Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies

McGill Percy KC, Liu Z, Qi X.

Neurotherapeutics. 2025 Apr;22(3):e00525. doi: 10.1016/j.neurot.2025.e00525. Epub 2025 Jan 17.

The potential link between the development of Alzheimer's disease and osteoporosis

Nasme F, Behera J, Tyagi P, Debnath N, Falcone JC, Tyagi N.

Biogerontology. 2025 Jan 20;26(1):43. doi: 10.1007/s10522-024-10181-z.

The role of α-tocopherol in the prevention and treatment of Alzheimer's disease

Pelczarski M, Wolaniuk S, Zaborska M, Sadowski J, Sztangreciak-Lehun A, Bułdak RJ.

Mol Cell Biochem. 2025 Jun;480(6):3385-3398. doi: 10.1007/s11010-025-05214-1. Epub 2025 Jan 20.

Nuclear Tau accumulation in Alzheimer's disease

Chinnathambi S, Velmurugan G, Suresh S, Adithyan A, Chandrashekar M.

Adv Protein Chem Struct Biol. 2025;143:323-337. doi: 10.1016/bs.apcsb.2024.06.003. Epub 2024 Jun 21.

Histone deacetylase's regulates Tau function in Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;143:339-361. doi: 10.1016/bs.apcsb.2024.09.008. Epub 2024 Oct 7.

Nuclear transport protein suppresses Tau neurodegeneration

Chinnathambi S, Adithyan A, Suresh S, Velmurugan G, Chandrashekar M, Sahu S, Mishra M.

Adv Protein Chem Struct Biol. 2025;143:363-385. doi: 10.1016/bs.apcsb.2024.07.001. Epub 2024 Jul 26.

Nuclear podosomes regulates cellular migration in Tau and Alzheimer's disease

Qureshi T, Chandrashekar M, Ananthanarayana V, Kumarappan M, Rangappa N, Velmurugan G, Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;143:411-426. doi: 10.1016/bs.apcsb.2024.09.009. Epub 2024 Oct 2.

Communicating scientific evidence: drugs for Alzheimer's disease as a case study

Kepp KP, Høilund-Carlsen PF, Cristea IA, Cumming RG, Daly T, Emilsson L, Flacco ME, Hemkens LG, Janiaud P, Johnsen KB, Lallukka T, Muka T, Naudet F, Revheim MR, Squitti R, Thambisetty M.

Curr Med Res Opin. 2025 Feb;41(2):347-354. doi: 10.1080/03007995.2025.2458530. Epub 2025 Feb 5.

Deciphering the Role of Adrenergic Receptors in Alzheimer's Disease: Paving the Way for Innovative Therapies

Miliotou AN, Kotsoni A, Zacharia LC.

Biomolecules. 2025 Jan 15;15(1):128. doi: 10.3390/biom15010128.

Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications

He S, Xu Z, Han X.

Mol Neurodegener. 2025 Jan 27;20(1):11. doi: 10.1186/s13024-025-00803-6.

Cell-specific transcriptional signatures of vascular cells in Alzheimer's disease: perspectives, pathways, and therapeutic directions

Chaudhuri S, Cho M, Stumpff JC, Bice PJ, İş Ö, Ertekin-Taner N, Saykin AJ, Nho K.

Mol Neurodegener. 2025 Jan 29;20(1):12. doi: 10.1186/s13024-025-00798-0.

Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer's disease

Singh S, Singh RK.

Mol Biol Rep. 2025 Jan 29;52(1):173. doi: 10.1007/s11033-025-10297-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias